▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $29.14.
The current consensus among 1 polled investment analysts is to hold stock in Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt..
Richter Gedeon VegyÃ©szeti GyÃ¡r NyilvÃ¡nosan MukÃ¶do Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. It operates in two segments, Pharmaceuticals, and Wholesale and Retail. The company focuses on the development and manufacture of products in various therapeutic areas, including gynecological, cardiovascular, and central nervous system. Its gynecological products include contraceptives, emergency contraceptives, hormone replacements, fungicides, and preparations used for the treatment of uterine fibroids. The company also offers central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, it produces various over-the-counter products for various health problems comprising Escapelle (Postinor), an emergency contraceptive pill; Panangin for supporting cardiovascular health; Stopdiar to treat diarrhea; Lordestin and Zilola for allergy; and Curiosin for wound care. The company was founded in 1901 and is headquartered in Budapest, Hungary.